4
Changes in Ownership
Amylyx Pharmaceuticals, Inc. Filed Acc 0000950170-24-045693
Chief Medical Officer acquired 96,910 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Bedrosian Camille L Chief Medical Officer | 2024-04-16 | Grant or award | +96,910 | 155,243 | D | ||
| Derivatives | |||||||
| Bedrosian Camille L Chief Medical Officer | 2024-04-16 | Grant or award · Stock Option (Right to Buy) | +120,000 | 120,000 | D | ||
Loading xslF345X05/ownership.xml…